News

Published on 26 Jan 2025 on Zacks · via Yahoo Finance

New Strong Buy Stocks for January 27th

Article preview image

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Alnylam Pharmaceuticals, Inc. ALNY: This biopharmaceutical company has seen the...

Read the rest of the article
NASDAQ.ALNY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
New Strong Buy Stocks for January 27th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Alnylam Pharmaceuticals,...

Zacks · via Yahoo Finance 26 Jan 2025
Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks · via Yahoo Finance 23 Jan 2025
Exploring High Growth Tech Stocks in the US December 2024

The United States market has recently experienced a 2.8% increase over the past week and a...

Simply Wall St. · via Yahoo Finance 26 Dec 2024
Is Alnylam Pharmaceuticals, Inc. (ALNY) the Best Performing Biotech Stock in...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 23 Dec 2024
Why Is Alnylam Pharmaceuticals, Inc. (ALNY) Among the Best High Growth...

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this...

Insider Monkey · via Yahoo Finance 2 Dec 2024
Should Invesco NASDAQ Next Gen 100 ETF (QQQJ) Be on Your Investing Radar?

Looking at individual holdings, Applovin Corp (APP) accounts for about 3.20% of total assets,...

Zacks · via Yahoo Finance 29 Nov 2024
Biotech ETF (XBI) ended a diagonal – Looking for buying dips

The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that tracks the biotechnology segment o...

The Forex Market 27 Nov 2024
BridgeBio Stock Up on FDA Approval of Cardiovascular Drug

BBIO gets a significant boost with the FDA approval of acoramidis for the treatment of adults wit...

Zacks · via Yahoo Finance 26 Nov 2024
FDA Begins Review of Alnylam's sNDA for Expanded Amvuttra Use

Alnylam Pharmaceuticals, Inc. Price and Consensus Alnylam Pharmaceuticals, Inc....

Zacks · via Yahoo Finance 26 Nov 2024
Exploring Three High Growth Tech Stocks In The United States

The United States market has shown robust performance, climbing by 2.2% over the past week with a...

Simply Wall St. · via Yahoo Finance 25 Nov 2024

Copyright Statfolio @ 2025

Social Accounts